GLP-1 therapies, or glucagon-like peptide-1 receptor agonists , represent a remarkable shift in how we approach type 2 diabetes . These new therapies help stimulating the body’s own GLP-1 substance , https://glp-3-rt163756.robhasawiki.com/user